press

September 17, 2020
September 17, 2020

Obsidian Therapeutics Appoints Jan ter Meulen, M.D., Ph.D., as Chief Scientific Officer

Do you like it?
Read more
September 15, 2020
September 15, 2020

Obsidian Therapeutics Announces Bristol Myers Squibb Opt-In of cytoDRiVE™ Cell Therapy Candidate

Do you like it?
Read more
September 3, 2020
September 3, 2020

Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors

Do you like it?
Read more
May 1, 2020
May 1, 2020

Obsidian Therapeutics Develops and Shares Safe Workplace Productivity Solution in Response to COVID19

Do you like it?
Read more
March 3, 2020
March 3, 2020

Obsidian Therapeutics Appoints Anders Götzsche to Board of Directors

Do you like it?
Read more
February 5, 2020
February 5, 2020

Obsidian Therapeutics Announces Formation of Scientific Advisory Board

Do you like it?
Read more
November 12, 2019
November 12, 2019

Obsidian Therapeutics Announces Expansion of Leadership Team

Do you like it?
Read more
September 24, 2019
September 24, 2019

Obsidian Therapeutics Appoints Erin Boyer as Vice President, Human Resources

Do you like it?
Read more
July 25, 2019
July 25, 2019

Obsidian Therapeutics Announces Strengthening of Executive Leadership Team

Do you like it?
Read more
12
Next page
0